Cosmos Holdings Inc. (COSM), whose stock is qualified for quotation on
the OTCQB under the symbol “COSM,” is proud to announce that the Company
entered into an “EXCLUSIVE COOPERATION AGREEMENT” with Mr. Grigorios
Siokas to assume the position of Manager of Pharmaceutical Division of
It is anticipated that he will be engaged solely by COSMOS, mainly in
the fields of Pharmaceutical business development in Greece, Germany,
United Kingdom and another EU country for the first few years. After
that we are currently planning to develop these and other pharmaceutical
activities in a broader geographical area. More specifically, it is his
job under the EXCLUSIVE COOPERATION AGREEMENT to incorporate, manage,
structure and organize five companies (2 Greek, 1 German, 1 UK and
another EU company –i.e. Polish), in the following six years, dedicated
to medicine import – export that will be 100% owned subsidiaries of
Cosmos Holdings Inc. His duties will encompass the identification,
planning, strategizing and negotiation with potential strategic business
partners and in general assisting with business development of the
Mr. Siokas’ has significant background and experience in the business
area of Pharmaceutical Imports - Exports. He comes to Cosmos Holdings
with over 15 years of management experience in the sector, most recently
as General Director at ZED Pharma S.A where he directed the efforts,
from January of 2011 to March 2014.
Prior to ZED Pharma S.A. Mr. Siokas was the General Director from June
of 2004 until October of 2010 at IPPOKRATIS S.A, a company that is
operating in the business of Pharmaceutical Exports. During his tenure
with IPPOKRATIS S.A the company achieved combined annual sales through
the several programs he managed totaling 105 million dollars per year,
in that company’s fiscal year ended 2009.
Mr. Siokas holds a Bachelor degree from the “Aristotle University of
Thessaloniki” and the Geology Department where he graduated in the year
Cosmos Holding’s President & CEO Mr. Dimitrios Goulielmos Commented; “We
are very pleased that Mr. Siokas has joined Cosmos Holding, Inc. His
significant experience in the Pharmaceutical import – export business
combined with his educational experience make him uniquely qualified for
what we see to be his role at Cosmos Holdings Inc. We believe that he is
an accomplished manager in this sector, with a great track record
working for companies, the last of which as noted above where he
assisted through his management work in generating significant profits.
We hope his expertise will assist us in achieving aggressive growth in
this type of business. We continue to follow our underlying principle
'Strength through Diversity and Returns.'
Mr. Siokas notes "I am very pleased to become an integral part of Cosmos
Holding’s pharmaceutical division and look forward to working with
Company’s management to achieve all of the business and financial
objectives that are in place for the pharmaceuticals division. I am
eager and ready to contribute all my know-how and managerial skills to
help Cosmos grow as quickly as possible.”
About Cosmos Holdings, Inc.
Cosmos Holdings is a Holding Company and an OTC QB listed company under
the symbol “COSM”. The Company is currently actively looking for
potential acquisition candidates in various industries including but not
limited to pharmaceutical industry and related pharmaceutical logistics
companies, food industry, green and Hi-Tech technologies, and insurance
This press release contains forward-looking statements within the
meaning of the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. These forward-looking statements can be
identified by words such as "will," "may," "expect," "anticipate,"
"aim," "intend," "plan," "believe," "estimate," "potential," "continue,"
and other similar statements. Statements other than statements of
historical facts in this announcement are forward-looking statements,
including but not limited to, our expectations regarding the expansion
of our manufacturing capacities, our future business development, and
our beliefs regarding our production output and production outlook.
These forward-looking statements involve known and unknown risks and
uncertainties and are based on current expectations, assumptions,
estimates and projections about the Company and the industry. Further
information regarding these and other risks is included in documents
filed with the Securities and Exchange Commission. The Company
undertakes no obligation to update forward-looking statements, except as
may be required by law. Although the Company believes that the
expectations expressed in these forward-looking statements are
reasonable, it cannot assure you that its expectations will turn out to
be correct, and investors are cautioned that actual results may differ
materially from the anticipated results.
Cosmos Holdings, Inc.
Source: Cosmos Holdings Inc.